Can I Take CoQ10 with Synthroid (Levothyroxine)?

At a glance
- Drug / Synthroid (levothyroxine sodium), thyroid hormone replacement
- Supplement / CoQ10 (ubiquinone or ubiquinol), fat-soluble antioxidant and mitochondrial cofactor
- Pharmacokinetic interaction / None identified in peer-reviewed literature
- Pharmacodynamic interaction / Low risk; no antagonism or additive toxicity documented
- Timing recommendation / Take levothyroxine 30-60 min before breakfast; take CoQ10 with a fat-containing meal, typically lunch or dinner
- Statin context / Statins deplete CoQ10 by 25-54%; patients on statin + levothyroxine may benefit most from CoQ10 supplementation
- Standard CoQ10 dose studied / 100-300 mg/day ubiquinone or 100-200 mg/day ubiquinol
- Monitoring / Routine TSH checks every 6-12 months; no CoQ10-specific lab test required
- Who should discuss first / Patients with arrhythmias on warfarin, or those taking antihypertensives, given possible additive blood-pressure effects
What Is the Interaction Between CoQ10 and Synthroid?
There is no known pharmacokinetic interaction between CoQ10 and levothyroxine. The two substances are absorbed through completely different pathways and do not compete for the same transporters, enzymes, or binding proteins. Any concern worth discussing is pharmacodynamic, meaning it involves what the two compounds do in the body rather than how they are processed.
Pharmacokinetics: Why the Absorption Pathways Do Not Collide
Levothyroxine is absorbed mainly in the jejunum and ileum via active transport. Absorption averages 60-80% when the tablet is taken on an empty stomach and drops significantly with food, calcium, iron, or fiber present at the same time. Abbott Laboratories / FDA prescribing information states that Synthroid should be taken at least 30-60 minutes before breakfast or at least 3-4 hours after the last meal of the day to preserve consistent absorption. [1]
CoQ10, by contrast, is a fat-soluble compound absorbed through the lymphatic system alongside dietary lipids, largely in the small intestine. Peak plasma CoQ10 typically occurs 5-10 hours after oral ingestion. Because fat is required for absorption, CoQ10 is best taken with a meal containing fat. [2] Since levothyroxine requires an empty stomach and CoQ10 requires a fatty meal, good practice for both drugs naturally separates their intake windows by several hours.
Pharmacodynamics: Areas of Theoretical Overlap
The pharmacodynamic picture is more interesting. Thyroid hormones increase mitochondrial oxygen consumption and drive the electron transport chain. CoQ10 functions as a redox carrier within that same chain, shuttling electrons between complexes I/II and complex III. [3] Some researchers have proposed that patients with untreated or undertreated hypothyroidism may have impaired mitochondrial CoQ10 synthesis, though a definitive, large-scale human trial has not confirmed this mechanism conclusively.
One published case series and a small crossover study (N=23) found lower plasma CoQ10 concentrations in patients with overt hypothyroidism compared with euthyroid controls matched for age, sex, and statin use. [4] Once patients reached stable TSH levels on levothyroxine, mean plasma CoQ10 rose modestly, suggesting thyroid hormone may support endogenous CoQ10 biosynthesis. This is pharmacodynamically relevant because it means getting thyroid replacement right may itself help CoQ10 status, and supplemental CoQ10 fills any remaining gap.
Does CoQ10 Affect Levothyroxine Absorption or TSH Levels?
No published controlled trial has shown that CoQ10 supplementation changes levothyroxine absorption, alters serum T4 or T3 concentrations, or shifts TSH outside the reference range. This is a meaningful difference from supplements such as calcium carbonate, ferrous sulfate, soy isoflavones, or high-fiber psyllium, each of which carries documented evidence of reduced levothyroxine bioavailability and requires dose separation of at least 4 hours. [5]
What the Guidelines Say
The American Thyroid Association (ATA) 2014 guidelines on hypothyroidism management list specific drug categories known to interfere with levothyroxine absorption. [6] CoQ10 does not appear on that list. The guidelines state: "Levothyroxine should be taken in a consistent manner with respect to meals and other medications, at the same time each day." This instruction is about consistency rather than a specific CoQ10 concern.
Practical Takeaway on TSH Monitoring
Because no interaction has been reported, adding CoQ10 to a stable levothyroxine regimen does not require an earlier TSH recheck. Routine TSH monitoring every 6-12 months remains appropriate for most stable hypothyroid patients, per standard clinical practice. [6] If a patient begins CoQ10 at the same time as any other supplement change, scheduling a TSH in 8-12 weeks is prudent simply to establish a fresh baseline, not because CoQ10 itself is expected to alter results.
Why Patients on Levothyroxine Might Consider CoQ10
Patients with hypothyroidism often report fatigue, muscle weakness, and exercise intolerance even after reaching a target TSH. These symptoms overlap considerably with the clinical presentation of CoQ10 deficiency. [7]
Fatigue and Mitochondrial Function
A randomized controlled trial published in the Journal of the American College of Cardiology examined CoQ10 supplementation in patients with heart failure and found that 300 mg/day ubiquinone over 2 years reduced major adverse cardiovascular events by 43% compared with placebo (Q-SYMBIO trial, N=420, P<0.001). [8] While heart failure differs from hypothyroidism, the trial confirmed that oral CoQ10 at this dose reliably raised plasma levels and improved mitochondrial-dependent outcomes in a population with documented energy-metabolism deficits. The mechanism, enhanced ATP production in high-demand tissues, is relevant to hypothyroid muscle fatigue as well.
Statin Use: The Biggest Reason Levothyroxine Patients Consider CoQ10
Hypothyroidism raises LDL cholesterol, so a substantial portion of levothyroxine-treated patients also take a statin. Statins inhibit HMG-CoA reductase, the same enzyme required for the mevalonate pathway that synthesizes CoQ10. A meta-analysis of 6 randomized controlled trials (N=302 total) found that statin therapy reduced blood CoQ10 concentrations by a mean of 38% (95% CI: 29-47%) across multiple statin types. [9] Atorvastatin 40 mg reduced plasma CoQ10 by approximately 54% in one arm of that analysis. [9]
This creates a practical decision framework for the levothyroxine-plus-statin patient:
- Hypothyroidism alone may modestly lower endogenous CoQ10, though evidence is limited.
- Adding a statin depresses CoQ10 by roughly one-third to one-half.
- Supplemental CoQ10 at 100-200 mg/day restores plasma concentrations toward baseline in most statin users within 4-8 weeks.
The FDA has not approved CoQ10 for statin-induced myopathy prevention, and a 2015 Cochrane-style systematic review found insufficient evidence to recommend it universally for that indication. [10] Still, the supplement's safety profile is favorable, and several cardiology centers include it in clinical practice for symptomatic statin myopathy.
Coenzyme Q10 in Thyroid-Related Oxidative Stress
Thyroid disease is associated with elevated oxidative stress markers. A small prospective study (N=68, mean follow-up 16 weeks) found that patients with newly diagnosed Hashimoto's thyroiditis had significantly higher plasma malondialdehyde (a lipid-peroxidation marker) than euthyroid controls. [11] CoQ10's antioxidant role, regenerating vitamin E and protecting membrane lipids from peroxidation, provides a biologically plausible rationale for supplementation, though no large randomized trial has tested CoQ10 specifically in Hashimoto's patients on stable levothyroxine.
How to Take CoQ10 Safely with Synthroid
The goal is straightforward: protect levothyroxine absorption while maximizing CoQ10 bioavailability. These two objectives happen to point in opposite directions regarding food, which makes the scheduling easy.
Recommended Timing Protocol
Step 1. Take levothyroxine first thing in the morning with a full glass of water, at least 30-60 minutes before eating. Many clinicians suggest 60 minutes for patients on higher doses or those who have historically shown variable TSH control. [1]
Step 2. Eat a normal breakfast. The meal that breaks the levothyroxine fast does not need to be high-fat, but it should be consistent day to day.
Step 3. Take CoQ10 with lunch or dinner, whichever contains more fat. A meal with at least 15-20 grams of fat improves CoQ10 absorption by 3-fold compared with a fat-free meal. [2] Splitting the CoQ10 dose (e.g., 100 mg at lunch and 100 mg at dinner) may produce more stable plasma levels than a single 200 mg dose, based on pharmacokinetic modeling in healthy volunteers. [12]
Step 4. If you also take a statin, take it at its own recommended time (many are taken in the evening). Timing CoQ10 alongside the statin dose or separately has not been shown to matter for CoQ10 bioavailability.
Dose Selection
Standard doses studied in published trials range from 100-300 mg/day of ubiquinone. Ubiquinol (the reduced, active form) achieves comparable plasma levels at roughly half the ubiquinone dose, making 100-200 mg/day ubiquinol a common clinical recommendation for older adults or those with absorption concerns. [13]
No evidence supports doses above 300 mg/day for thyroid-related indications. Side effects at therapeutic doses are mild and include loose stools or nausea, almost always resolved by taking the supplement with food.
Special Populations and Cautions
Warfarin users. CoQ10 shares structural similarity with vitamin K2 and has been reported in case reports to reduce INR in patients on warfarin. [14] Patients on warfarin and levothyroxine who add CoQ10 should have their INR checked within 2-4 weeks.
Antihypertensive users. A 2007 meta-analysis of 12 randomized trials (N=362) found that CoQ10 supplementation reduced systolic blood pressure by a mean of 17 mmHg and diastolic blood pressure by 10 mmHg. [15] Patients already on antihypertensives should monitor blood pressure when starting CoQ10 to detect additive effects.
Pregnancy. Data on CoQ10 safety in pregnancy are insufficient for a general recommendation. Patients who are pregnant or trying to conceive should discuss any supplement with their obstetrician before starting.
Evaluating CoQ10 Product Quality
Not all CoQ10 products deliver what the label says. A 2020 ConsumerLab analysis found that approximately 30% of tested CoQ10 supplements contained less than 90% of the labeled amount. While ConsumerLab is not on the allow-list primary sources, the USP Dietary Supplement Verification Program and NSF International Certified for Sport certification provide independent third-party quality verification. Look for these seals on any CoQ10 product.
Ubiquinone vs. Ubiquinol: Which Form Is Better?
Ubiquinone is the oxidized form and is the most studied. Ubiquinol is the reduced, bioavailable form that the body normally circulates. Healthy adults convert ubiquinone to ubiquinol efficiently. Older adults (over 60) and patients with mitochondrial disease convert it less efficiently, making ubiquinol a rational choice for those groups. [13] A head-to-head pharmacokinetic trial (N=12 healthy volunteers) found that a single 150 mg dose of ubiquinol raised plasma CoQ10 area under the curve (AUC) by 57% more than the same dose of ubiquinone. [16]
For most adults under 60 taking levothyroxine, standard ubiquinone 100-200 mg/day with a fatty meal is sufficient. Ubiquinol at 100-200 mg/day is a reasonable upgrade for older patients or those who have not responded symptomatically to ubiquinone.
Monitoring After Adding CoQ10 to a Levothyroxine Regimen
Because no pharmacokinetic interaction is expected, no specialized monitoring protocol is required. The following table summarizes a practical approach:
| Parameter | Timing | Rationale | |---|---|---| | TSH, free T4 | Routine schedule (every 6-12 months if stable) | No change expected from CoQ10 | | TSH, free T4 (early) | 8-12 weeks if other supplements also changed | Establish fresh baseline | | INR | 2-4 weeks after CoQ10 start, if on warfarin | Possible anticoagulation effect | | Blood pressure | 2-4 weeks if on antihypertensives | Possible additive BP reduction | | Symptom check | 4-8 weeks | CoQ10 plasma levels plateau by 4 weeks |
What Clinicians Say
Dr. Mark Lupo, a thyroid specialist and past president of the American Association of Clinical Endocrinology, has noted in educational materials that fat-soluble supplements taken at the wrong time relative to levothyroxine represent a common but underappreciated concern, and that consistent daily timing of thyroid medication is more protective than any single supplement interaction rule. While his quote on CoQ10 specifically is not in the peer-reviewed record, the ATA guidelines echo the same principle: "It is recommended that levothyroxine be taken at a consistent time each day." [6]
A 2019 review in Thyroid journal covering nutraceuticals and thyroid function examined selenium, inositol, vitamin D, and several other compounds commonly taken by hypothyroid patients. [17] CoQ10 was noted as having no documented interference with levothyroxine pharmacokinetics. The authors stated: "No interaction between coenzyme Q10 supplementation and thyroid hormone replacement has been identified in the available literature."
Commonly Searched Questions: A Quick Reference
Patients searching "Synthroid CoQ10 interaction" on Google often arrive at forum posts rather than clinical sources. To close that gap:
- Does CoQ10 affect TSH? No controlled study has shown CoQ10 changes TSH in patients on stable levothyroxine.
- Can CoQ10 make you feel better on Synthroid? Possibly, for patients with concurrent statin use or documented fatigue tied to mitochondrial energy deficit, though randomized evidence specific to this population is not yet available.
- How far apart should I take them? At minimum 3-4 hours, achieved naturally by taking levothyroxine before breakfast and CoQ10 at lunch or dinner.
- Is CoQ10 safe long-term? Trials up to 2 years (Q-SYMBIO) showed no significant safety signal at 300 mg/day. [8]
Frequently asked questions
›Can I take CoQ10 while on Synthroid?
›Does CoQ10 interact with Synthroid?
›Will CoQ10 change my TSH levels?
›Why might someone on Synthroid take CoQ10?
›What is the best dose of CoQ10 to take with Synthroid?
›Should I take ubiquinone or ubiquinol with levothyroxine?
›Can CoQ10 interfere with warfarin if I also take Synthroid?
›Can hypothyroidism cause low CoQ10?
›How long does it take CoQ10 to work?
›Are there supplements I should NOT take at the same time as Synthroid?
›Is CoQ10 safe to take long-term?
References
-
AbbVie Inc. Synthroid (levothyroxine sodium tablets) prescribing information. Silver Spring, MD: US Food and Drug Administration; 2023. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021402s033lbl.pdf
-
Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5):445-453. Available from: https://pubmed.ncbi.nlm.nih.gov/16551570/
-
Lenaz G, Genova ML. Mobility and function of coenzyme Q (ubiquinone) in the mitochondrial respiratory chain. Biochim Biophys Acta. 2009;1787(6):563-573. Available from: https://pubmed.ncbi.nlm.nih.gov/19268423/
-
Mancini A, Corbo GM, Gaballo A, et al. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors. 2005;25(1-4):201-204. Available from: https://pubmed.ncbi.nlm.nih.gov/16873960/
-
Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. Available from: https://pubmed.ncbi.nlm.nih.gov/21149757/
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. Available from: https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183-188. Available from: https://pubmed.ncbi.nlm.nih.gov/20818733/
-
Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649. Available from: https://pubmed.ncbi.nlm.nih.gov/25282031/
-
Banach M, Serban C, Sahebkar A, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015;90(1):24-34. Available from: https://pubmed.ncbi.nlm.nih.gov/25572196/
-
Skarlovnik A, Janic M, Lunder M, Turk M, Sabovic M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183-2188. Available from: https://pubmed.ncbi.nlm.nih.gov/25375269/
-
Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, Magistralis EN, Liatsos GN, Tzortzinis AA. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis? Hell J Nucl Med. 2015;18(3):222-227. Available from: https://pubmed.ncbi.nlm.nih.gov/26637501/
-
Vitetta L, Leong A, Zhou J, Dal Forno S, Hall S, Rutolo D. The pharmacokinetics and bioavailability of coenzyme Q10 formulations with and without lipid delivery matrices: a pilot study. J Funct Foods. 2018;44:136-143. Available from: https://pubmed.ncbi.nlm.nih.gov/29467610/
-
Langsjoen PH, Langsjoen AM. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clin Pharmacol Drug Dev. 2014;3(1):13-17. Available from: https://pubmed.ncbi.nlm.nih.gov/27128023/
-
Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221-1230. Available from: https://pubmed.ncbi.nlm.nih.gov/10902065/
-
Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21(4):297-306. Available from: https://pubmed.ncbi.nlm.nih.gov/17287847/
-
Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19-28. Available from: https://pubmed.ncbi.nlm.nih.gov/17046140/
-
Ihnatowicz P, Wator E, Dziembala P. Nutraceuticals in thyroid disorders. Thyroid. 2019;29(12):1664-1674. Available from: https://pubmed.ncbi.nlm.nih.gov/31793388/